ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Olmesartan Medoxomil in Hypertension and Renal Impairment

This study has been completed.
Information provided by Daiichi Sankyo Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Essential Hypertension
Renal Impairment
2 Additional conditions recognized in this trial
Hypertension
3 More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
4 Interventions listed in this trial
Olmesartan medoxomil
Losartan
Furosemide
5 More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Diuretics
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sodium Potassium Chloride Symporter Inhibitors
Therapeutic Uses
6 Sponsors listed in this trial
Sankyo Pharma Gmbh




Links to all studies - primarily for crawlers